As Fonterra faces questions over the sudden departure of its briefly-serving chief financial officer, the company’s farmer-owners are taking it to task over.
A jury in the US has ordered one of the world’s largest pharmaceutical conglomerates to pay US$175 million (NZ$300 million) to a man who said he developed.